Inventor · disambiguated record
Vernon G. Wong
Also filed as: WONG VERNON · WONG VERNON G
53 granted patents·23 pending applications·8,675 citations·filing 1982–2024
99Inventor score
Top patents by PatentIndex Score
76 records- 0199US6699493B2Method for reducing or preventing transplant rejection in the eye and intraocular implants for use thereforOCULEX PHARM INC·Filed 2001·Granted Mar 2, 2004·345 cites·45 claims
- 0299US4521210AEye implant for relieving glaucoma, and device and method for use therewithWONG VERNON G·Filed 1982·Granted Jun 4, 1985·635 cites·28 claims
- 0398US8071120B2Methods for treating neovascularization and intravitreal implantsWONG VERNON G·Filed 2006·Granted Dec 6, 2011·41 cites·3 claims
- 0498US7906136B2Conveniently implantable sustained release drug compositionsRAMSCOR INC·Filed 2005·Granted Mar 15, 2011·131 cites·9 claims
- 0598US7846468B2Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use thereforALLERGAN INC·Filed 2008·Granted Dec 7, 2010·40 cites·6 claims
- 0698US6726918B1Methods for treating inflammation-mediated conditions of the eyeOCULEX PHARM INC·Filed 2000·Granted Apr 27, 2004·331 cites·42 claims
- 0798US5869079AFormulation for controlled release of drugs by combining hydrophilic and hydrophobic agentsOCULEX PHARM INC·Filed 1995·Granted Feb 9, 1999·639 cites·1 claims
- 0898US5443505ABiocompatible ocular implantsOCULEX PHARM INC·Filed 1993·Granted Aug 22, 1995·1.1k cites·19 claims
- 0998US5164188ABiodegradable ocular implantsVISIONEX INC·Filed 1989·Granted Nov 17, 1992·593 cites·7 claims
- 1098US4997652ABiodegradable ocular implantsVISIONEX·Filed 1989·Granted Mar 5, 1991·695 cites·17 claims
- 1198US4853224ABiodegradable ocular implantsVISIONEX·Filed 1987·Granted Aug 1, 1989·568 cites·12 claims
- 1297US8722728B2Composition and method for treating dry eye syndromeWONG VERNON G·Filed 2009·Granted May 13, 2014·29 cites·28 claims
- 1397US7767223B2Methods for reducing or preventing transplant rejection in the eye and intraocular implants for useALLERGAN INC·Filed 2005·Granted Aug 3, 2010·27 cites·26 claims
- 1497US7625582B2Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use thereforALLERGAN INC·Filed 2007·Granted Dec 1, 2009·36 cites·6 claims
- 1597US7048946B1Formulation for controlled release of drugs by combining hyrophilic and hydrophobic agentsALLERGAN INC·Filed 1998·Granted May 23, 2006·168 cites·12 claims
- 1697US7033605B2Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use thereforALLERGAN INC·Filed 2003·Granted Apr 25, 2006·68 cites·32 claims
- 1797US6369116B1Composition and method for treating glaucomaOCULEX PHARM INC·Filed 1998·Granted Apr 9, 2002·372 cites·19 claims
- 1897US5824072ABiocompatible ocular implantsOCULEX PHARM INC·Filed 1996·Granted Oct 20, 1998·689 cites·17 claims
- 1996US11234926B2Liquid depot for non-invasive sustained delivery of agents to the eyeChibi Inc·Filed 2020·Granted Feb 1, 2022·4 cites·10 claims
- 2096US8541413B2Sustained release eye drop formulationsWONG VERNON G·Filed 2008·Granted Sep 24, 2013·25 cites·6 claims
- 2196US8242099B2Implants and methods for treating inflammation-mediated conditions of the eyeWONG VERNON G·Filed 2011·Granted Aug 14, 2012·27 cites·5 claims
- 2296US8043628B2Methods for reducing edemaALLERGAN INC·Filed 2007·Granted Oct 25, 2011·23 cites·4 claims
- 2396US6331313B1Controlled-release biocompatible ocular drug delivery implant devices and methodsOCULEX PHARMACETICALS INC·Filed 1999·Granted Dec 18, 2001·1k cites·19 claims
- 2496US5766242ABiocompatible ocular implantsOCULEX PHARM INC·Filed 1996·Granted Jun 16, 1998·696 cites·5 claims
- 2595US11497710B2Eye drop formulation and method for sustained delivery of medicament to the retinaChibi Inc·Filed 2020·Granted Nov 15, 2022·4 cites·11 claims
- 2695US10744202B2Sustained release eye drop formulationsRAMSCOR INC·Filed 2018·Granted Aug 18, 2020·8 cites·3 claims
- 2795US8088407B2Method for reducing or preventing transplant rejection in the eye and intraocular implants for use thereforWONG VERNON G·Filed 2007·Granted Jan 3, 2012·16 cites·5 claims
- 2894US9474736B2Composition and method for treating dry eye syndromeRAMSCOR INC·Filed 2015·Granted Oct 25, 2016·7 cites·26 claims
- 2994US9289428B2Conveniently injectable or implantable sustained-release antioxidant formulations for therapies of ocular maladies or cancerWONG VERNON G·Filed 2012·Granted Mar 22, 2016·14 cites·6 claims
- 3094US9011915B2Conveniently implantable sustained release drug compositionsWONG VERNON G·Filed 2011·Granted Apr 21, 2015·21 cites·3 claims
- 3193US8063031B2Implants and methods for treating inflammation-mediated conditions of the eyeWONG VERNON G·Filed 2009·Granted Nov 22, 2011·15 cites·1 claims
- 3292US9737606B2Sustained release eye drop formulationsRAMSCOR INC·Filed 2016·Granted Aug 22, 2017·5 cites·2 claims
- 3392US9144566B2Composition and method for treating dry eye syndromeRAMSCOR INC·Filed 2014·Granted Sep 29, 2015·7 cites·18 claims
- 3492US5632984AMethod of treatment of macular degenerationOCULEX PHARM INC·Filed 1994·Granted May 27, 1997·222 cites·9 claims
- 3591US12280141B2Liquid depot for non-invasive sustained delivery of agents to the eyeChibi Inc·Filed 2021·Granted Apr 22, 2025·1 cites·7 claims
- 3691US9012437B2Implants and methods for treating inflammation-mediated conditions of the eyeALLERGAN INC·Filed 2013·Granted Apr 21, 2015·11 cites·5 claims
- 3790US9993558B2Sustained release eye drop formulationsRAMSCOR INC·Filed 2013·Granted Jun 12, 2018·5 cites·5 claims
- 3890US9592242B2Methods for treating edema in the eye and intraocular implants for use thereforALLERGAN INC·Filed 2016·Granted Mar 14, 2017·4 cites·6 claims
- 3990US9283178B2Methods for treating edema in the eye and intraocular implants for use thereforALLERGAN INC·Filed 2014·Granted Mar 15, 2016·6 cites·6 claims
- 4088US12472142B2Liquid depot for non-invasive sustained delivery of agents to the eyeChibi Inc·Filed 2024·Granted Nov 18, 2025·0 cites·7 claims
- 4187US2025127713A1Liquid depot for non-invasive sustained delivery of agents to the eyeChibi Inc·Filed 2024·Application pending·0 cites
- 4284US10159683B2Use of sustained release dexamethasone in post-cataract surgery inflammationICON BIOSCIENCE INC·Filed 2018·Granted Dec 25, 2018·4 cites·14 claims
- 4383US9775849B2Implants and methods for treating inflammation-mediated conditions of the eyeALLERGAN INC·Filed 2015·Granted Oct 3, 2017·2 cites·6 claims
- 4482US10799642B2Dose guides for injection syringeICON BIOSCIENCE INC·Filed 2018·Granted Oct 13, 2020·4 cites·15 claims
- 4581US9814773B2Sustained release formulations for delivery of proteins to the eye and methods of preparing sameWONG VERNON G·Filed 2012·Granted Nov 14, 2017·5 cites·6 claims
- 4680US10206934B2Implants and methods for treating inflammation-mediated conditions of the eyeALLERGAN INC·Filed 2017·Granted Feb 19, 2019·1 cites·6 claims
- 4779US9283231B2Sustained release formulations for the treatment of intraocular pressure of glaucomaICON BIOSCIENCE INC·Filed 2014·Granted Mar 15, 2016·1 cites·12 claims
- 4878US8828446B2Method for reducing transplant rejection in the eye and intraocular implants for use thereforALLERGAN INC·Filed 2013·Granted Sep 9, 2014·1 cites·3 claims
- 4975US2023078906A1Sustained release dexamethasone formulationICON BIOSCIENCE INC·Filed 2022·Application pending·0 cites
- 5072US8894578B2Implantable MEMs intraocular pressure sensor devices and methods for glaucoma monitoringWONG VERNON G·Filed 2012·Granted Nov 25, 2014·11 cites·21 claims
Showing the top 50 of 76 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Vernon G. Wong files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →